Proton Therapy for Recurrent Nasopharyngeal Cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial uses proton therapy (a precise type of radiation) to treat people whose nasopharyngeal cancer has come back. It aims to see if this treatment can help control the cancer while limiting side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of throat cancer called squamous cell carcinoma of the nasopharynx that has come back (recurrent).
- Your cancer is at least stage T2b (a certain size or spread) and/or has spread to lymph nodes in the neck.
- You are physically active enough that your doctor rates your daily function as 0 or 1 on a standard scale.
- You are 18 years or older.
- Your doctors expect you to live at least 6 more months and you are healthy enough to handle radiation and chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding a PD-1 antibody (an immunotherapy) to standard chemoradiation can better control recurrent nasopharyngeal cancer that can’t be removed with surgery. If you qualify, you’d receive the study treatment and be closely monitored for side effects and cancer response.
This trial compares two ways of surgically treating localized, recurrent nasopharyngeal cancer: a low-temperature plasma radiofrequency method versus a standard high-frequency cautery method. You might be eligible if your recurrence is limited and can be surgically removed, and you are within the allowed health and age ranges.
This trial compares two treatments for early-stage nasopharyngeal cancer that has returned after radiation: surgery versus intensity-modulated radiation therapy (IMRT). The goal is to see which approach is more effective at controlling the cancer while keeping side effects manageable.
This trial studies toripalimab (an immunotherapy that helps your immune system attack cancer) for nasopharyngeal cancer that has come back locally. It may help shrink or control the returning tumor and improve outcomes for people who meet the safety and lab requirements.
This trial compares two types of radiation therapy for nasopharyngeal cancer that hasn't spread. Proton therapy is a newer type that may cause fewer side effects; this study tests if it works as well as standard photon therapy.
This trial tests a new way to plan radiation treatment for nasopharyngeal cancer, where the target area is tailored to each patient's tumor spread. It aims to improve effectiveness while reducing side effects.
Hear when a new Recurrent Nasopharyngeal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.